おすすめの製品
由来生物
synthetic
グレード
pharmaceutical primary standard
認証
EP Reference Standard
APIファミリー
famotidine
フォーム
solid
包装
pkg of 110 mg
メーカー/製品名
EDQM
保管条件
protect from light
アプリケーション
pharmaceutical (small molecule)
フォーマット
neat
輸送温度
ambient
保管温度
2-8°C
SMILES記法
N\C(N)=N\c1nc(CSCCC(=N)NS(N)(=O)=O)cs1
InChI
1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14)
InChI Key
XUFQPHANEAPEMJ-UHFFFAOYSA-N
遺伝子情報
human ... HRH2(3274)
類似した製品をお探しですか? 訪問 製品比較ガイド
詳細
Famotidine is a hydrophilic, cationic, histamine H2 receptor antagonist drug that effectively inhibits gastric acid secretion in humans.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
アプリケーション
This European Pharmacopoeia reference standard is intended for use only as specifically prescribed in the European Pharmacopoeia.
生物化学的/生理学的作用
H2ヒスタミンレセプタ-のアンタゴニストであり、抗潰瘍薬です。
包装
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
その他情報
Sales restrictions may apply.
関連製品
製品番号
詳細
価格
保管分類コード
11 - Combustible Solids
WGK
WGK 2
引火点(°F)
Not applicable
引火点(℃)
Not applicable
最新バージョンのいずれかを選択してください:
Famotidine
European pharmacopoeia, 29(1-2), 2609-2610 (2017)
Determination of cimetidine, famotidine, and ranitidine hydrochloride in the presence of their sulfoxide derivatives in pure and dosage forms by high-performance thin-layer chromatography and scanning densitometry
Journal of AOAC (Association of Official Analytical Chemists) International, 85(5), 1015-1020 (2002)
Stability indicating method for famotidine in pharmaceuticals using porous graphitic carbon column
Journal of Separation Science, 31(2) (2008)
Occupational allergic contact dermatitis from intermediate products in famotidine synthesis.
Contact dermatitis, 31(4), 259-260 (1994-10-01)
Clinical pharmacokinetics, 31(2), 103-110 (1996-08-01)
Famotidine, an H2 receptor antagonist, has several potential advantages over cimetidine and ranitidine. These advantages include its potency, relatively longer elimination half-life, and lack of interaction with the cytochrome P450 isoforms. Eight studies addressing the use of famotidine in paediatric
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)